Pandion Therapeutics Holdco LLC — Form D

Pandion Therapeutics Holdco LLC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-07. The offering totals $80.0M, of which $40.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2020-04-07
Form: D
Accession: 0001807901-20-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $80.0M
Amount sold: $40.0M
Remaining: $40.0M
Investors: 23
Date of first sale: 2020-03-23
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-364484

Issuer

Name: Pandion Therapeutics Holdco LLC
CIK: 0001807901
Entity type: Limited Liability Company
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 610 MAIN STREET, CAMBRIDGE, MA, 02139
Phone: 617-393-5924

Officers, directors & promoters (12)

Name	Role	Location
Daniel L Becker	Director	Cambridge, MA
Jill L Carroll	Director	Cambridge, MA
Alan L Crane	Director	Cambridge, MA
Donald L Frail	Director	Cambridge, MA
Christopher L Fuglesang	Director	Cambridge, MA
Rahul Kakkar	Director	CAMBRIDGE, MA
Mitchell L Mutz	Director	Cambridge, MA
Carlo L Rizzuto	Director	Cambridge, MA
Nancy L Stagliano	Director	Cambridge, MA
Vikas L Goyal	Executive Officer	Cambridge, MA
Rahul Kakkar	Executive Officer	CAMBRIDGE, MA
Jo L Viney	Executive Officer	Cambridge, MA

More